Dr Rebecca M. Nisbet
Honorary Principal Fellow
Florey Department of Neuroscience and Mental Health
8 Scholarly works
6 Projects
HIGHLIGHTS
2025
Research grants (international)
How Does APOE Christchurch Variant Protect Against Alzheimer's Disease?
2024
Journal article
Messenger RNA-encoded antibody approach for targeting extracellular and intracellular tau
DOI: 10.1093/braincomms/fcae1002023
Journal article
Quantitative proteomics of tau and Aβ in detergent fractions from Alzheimer's disease brains
DOI: 10.1111/jnc.157132022
Journal article
Ultrasound-mediated delivery of novel tau-specific monoclonal antibody enhances brain uptake but not therapeutic efficacy
DOI: 10.1016/j.jconrel.2022.07.0262022
Journal article
A sporadic Alzheimer’s blood-brain barrier model for developing ultrasound-mediated delivery of Aducanumab and anti-Tau antibodies
DOI: 10.7150/thno.726852021
Research grants (ARC, NHMRC, MRFF)
Development of an Intracellular Tau-Specific Antibody Therapeutic for the Treatment of Alzheimer's Disease
2021
Research Grant
Development of an Intracellular Tau-Specific Antibody Therapeutic for the Treatment of Alzheimer's Disease
RECENT SCHOLARLY WORKS
2021
Journal article
Current and emerging strategies for enhancing antibody delivery to the brain
DOI: 10.3390/pharmaceutics131220142021
Journal article
Citrullination of Amyloid-β Peptides in Alzheimer's Disease
DOI: 10.1021/acschemneuro.1c004742010
Journal article
Residues surrounding the glycosylphosphatidylinositol anchor attachment site of PrP modulate prion infection: Insight from the resistance of rabbits to prion disease
DOI: 10.1128/JVI.02709-092008
Journal article
Inhibition of γ-secretase causes increased secretion of amyloid precursor protein C-terminal fragments in association with exosomes
DOI: 10.1096/fj.07-9357com
RECENT PROJECTS
2024
Research grants (ARC, NHMRC, MRFF)
Centre of Research Excellence in Mechanisms in NeuroDegeneration \2013 Alzheimer\2019s Disease (MIND-AD CRE)
2024
Research grants (other domestic)
Vectorised Antibody Therapeutic Targeting Intracellular Tau for the Treatment of Alzheimer\2019s Disease
2023
Research grants (international)
Development of Next Generation Tau Immunotherapies- NCE